News Buzz: Regado Biosciences (NASDAQ:RGDO), CenturyLink (NYSE:CTL), Immunomedics Inc. (NASDAQ:IMMU), Select Comfort Corporation (NASDAQ:SCSS), BIND Therapeutics (NASDAQ:BIND)

On Tuesday shares of Regado Biosciences, Inc. (NASDAQ:RGDO) closed at $1.46. Regado Biosciences, Inc. (NASDAQ:RGDO) currently has a Zacks Rank #3 (Hold).

CenturyLink, Inc. (NYSE:CTL) in last trading activity increased 1.83% to close at $35.13. Company quarterly performance stands at -5.16%. CenturyLink, Inc. (NYSE:CTL) is -19.87% away from its 52 week high. CenturyLink, Inc. (NYSE: CTL) announced the availability of CenturyLink Cloud in Asia Pacific. The public cloud platform – available in the United States, United Kingdom, Canada and Germany, and now through one of CenturyLink’s data centers in Singapore – delivers enterprise-class control, agility, scalability and security backed by an industry-leading global network.

On last trading day Immunomedics Inc. (NASDAQ:IMMU) fell -1.66% to close at $4.14. Its volatility for the week is 3.49% while volatility for the month is 3.44%. IMMU’s sales growth for past 5 years was -21.40% and its EPS growth for past 5 years was -44.67%. Immunomedics Inc. (NASDAQ:IMMU) monthly performance is 7.81%. On 10 March 2015, Immunomedics Inc. (NASDAQ:IMMU) appointed Francois E. Wilhelm as chief medical officer of the company.

Select Comfort Corporation (NASDAQ:SCSS) has 0.70% insider ownership while its institutional ownership stands at 92.80%. In last trading activity company’s stock closed at $33.32. Kathryn Roedel, executive vice president — chief services and fulfillment officer of Select Comfort Corp. (NASDAQ:SCSS) has been elected to chair the board of the International Sleep Products Assn.

On last trading day BIND Therapeutics, Inc. (NASDAQ:BIND) increased 10.70% to close at $5.69. Its volatility for the week is 8.75% while volatility for the month is 5.68%. BIND Therapeutics, Inc. (NASDAQ:BIND) monthly performance is -6.11%. On 13 March 2015, BIND Therapeutics, Inc. (NASDAQ:BIND) appointed Andrew Hirsch as its new President and CEO.

Leave a Reply

Your email address will not be published. Required fields are marked *